<DOC>
	<DOCNO>NCT00090909</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , gemcitabine , cisplatin , dexamethasone , work different way stop cancer cell divide stop grow die . Combining one drug may kill cancer cell . PURPOSE : This phase II trial study well give gemcitabine cisplatin together dexamethasone work treat patient relapsed refractory Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Gemcitabine , Cisplatin , Dexamethasone Treating Patients With Relapsed Refractory Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate maximum response patient relapse refractory Hodgkin 's lymphoma treat gemcitabine , cisplatin , dexamethasone . - Determine time progression patient treat regimen undergo stem cell transplantation . - Determine toxicity regimen patient . OUTLINE : This open-label study . Patients receive gemcitabine IV 1 hour day 1 8 , cisplatin IV 3 hour day 1 , oral dexamethasone twice daily day 1-4 . Treatment repeat every 21 day 6 course absence disease progression unacceptable toxicity . Patients follow disease progression . PROJECTED ACCRUAL : A total 18-35 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Hodgkin 's lymphoma Measurable disease radiological clinical finding Failed least 1 , 2 , prior standard chemotherapy regimen Highdose chemotherapy administer chemotherapy course consider 2 course No evidence CNS disease No history myelodysplastic syndrome PATIENT CHARACTERISTICS : Age Over 18 Performance status ECOG 02 Life expectancy Not specify Hematopoietic WBC &gt; 2,000/mm^3 Absolute neutrophil count &gt; 1,500/mm^3 Platelet count &gt; 75,000/mm^3 Hemoglobin &gt; 8.0 g/dL Hepatic Bilirubin &lt; 2 time upper limit normal ( ULN ) AST ALT &lt; 5 time ULN Renal Creatinine &lt; 1.5 time ULN Other Not pregnant nursing Fertile patient must use effective contraception 3 month study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics No prior gemcitabine More 6 month since prior highdose chemotherapy Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
</DOC>